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Abstract
Components of variance have a long history and find application in all areas of scientific
investigation. This paper introduces components of variance and their importance firstly
by examples on blood pressure, proteomic data, breath analysers and oropharyngeal pH
monitoring devices. We then present an intuitive geometric representation of analysis
of variance and explain how the components of variance can be estimated from the
analysis of variance table. We conclude by suggesting practice points for studies which
incorporate components of variance, and recommend commonly used statistical software
to undertake such analysis.
Keywords: components of variance, analysis of variance, multilevel model, interob-
server agreement, Bland-Altman plot.
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1 Introduction to the key ideas
To a statistician, the term components of variance conjures up a linear statistical model
in which all the random variables are assumed to be independent and normally dis-
tributed. However, components of variance have a long history dating back several
centuries and much of the early work, which was in genetics and sampling, did not re-
quire such assumptions. In 1918, R.A. Fisher employed components of variance in his
work on Mendelian genetics and introduced the term Variance, then popularised the
analysis of variance1. L.C. Tippett later clarified the role of analysis of variance for
estimating components of variance using linear models. There was also a great deal of
activity in the 1930s by other well-known statisticians including H. Daniels on applica-
tion to the production of wool yarn and F. Yates on optimal sampling for yield in cereal
experiments. We recommend S. Stigler’s book2 to readers who are interested in the early
history of statistics.
Components of variance arise when the observed variation is attributable to sources
with direct physical meaning. Tomasetti and Vogelstein3 suggest that “only a third of
the variation in cancer risk among tissues is attributable to environmental factors or
inherited predispositions. The majority is due to ‘bad luck’, that is, random mutations
arising during DNA replication in normal, noncancerous stem cells.” Components of
variance find widespread application in the biomedical sciences in which many variables
are characterised by their variability. A key question is: what are components of variance
used for? A common aim is the estimation of a population mean, such as the true
level of a leaf parasite infection in a forest. The researcher has to first come to terms
with the variability between leaves on trees and the variability between trees in order to
determine how many trees and how many leaves within trees to sample. In this situation,
the variance components are of secondary interest to the primary purpose of the study,
which is the estimation of the true mean infection level. Alternatively, the study of
variability may be of primary interest in its own right. For example, in genetics the
variance components may describe total phenotypic variation that may be attributable
to genetic and environmental sources, or in industrial statistics the variance components
may be due to variability between observers or machines. In such cases, it is of specific
interest to know how much variability each source contributes to the overall variability,
and statistics provides us with the techniques to determine this.
Statistical models can include two main types of effects, fixed or random. Fixed
effects can be viewed as an attempt to estimate mean values from a population while
random effects can be viewed as an attempt to estimate the variance of a population.
When both types of effects are present, the model is referred to as mixed. Technically
of course, all statistical models that include a single error term have a random effect
but in these simple cases such a model is not referred to as being mixed. The effects
being modelled can also be nested, that is, specific to a sub-branch of the hierarchy, as
in the leaves on trees hierarchy, or crossed, that is, effects apply across branches of the
hierarchy, as say, observers would be crossed with machines in the industrial example.
Statistical interactions may also be present, as either fixed or random effects, in which
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different combinations of effects modify the outcome.
The fitting of variance components models to data was until recently hampered by
the complexity of the calculations involved, and the limited availability of computing
facilities and appropriate statistical programs. Fortunately, the situation has dramati-
cally improved over the past two decades and we discuss recommendations for current
software in Section 5. The relative ease of model-fitting and estimation today has led
to a resurgence of interest in variance components models and as their application has
become more widespread, so has the terminology. The simplest models are purely nested
in which the observed variation is the sum or one or more variance components arising
from a hierarchical structure; Example 2 below describes for a one-way nested model
for systolic blood pressure. Example 3 analyses data on breath analysers and extends
the one-way model to include a fixed effect for the breath analysers as well as a ran-
dom interaction term; such mixed models are also known as a multilevel, hierarchical or
random effects models. We present a more complex mixed effects model for proteomic
gastric cancer data in Example 4. An analysis of interobserver agreement for oropharyn-
geal pH monitoring devices is described in Example 5. We have endeavoured to include
examples of interest to the present readership, notwithstanding “The limited number of
public datasets for histopathology analysis”4.
Example 1. Consider a group of adult male patients each of whom has a ‘true’ but
unknown value of systolic blood pressure. Let µi denote this value for patient i, where
i = 1, . . . , I, and assume one measurement is made on each patient. Then for each µi,
the corresponding observation Yi may be written as a model:
Yi = µi +Ai,
where on the right hand side of the model equation, Ai is a random variable with mean




A is called the
component of variance within patients. In the case of random sampling from a single
homogeneous population, σ2A is also referred to as the component of variance for sampling
error, or measurement error, for blood pressure.
Example 2. Blood pressure data: Now suppose that the I patients in Example 1 are
regarded as a random sample representing the population of adult male patients. Then
each µi itself may be regarded as an observation on a random variableBi, with population
mean µ and variance σ2B, where µ is the unknown true mean systolic blood pressure of
the population, and σ2B is the component of variance between patients. That is, the
model for blood pressure observation Yi can now be written as
Yi = µ+Bi +Ai,
where E(Bi) = 0, var(Bi) = σ
2
B, and in the simplest case we assume the between-
patient random variables Bi and within-patient random variables Ai are uncorrelated,
i.e., cov(Ai, Bi) = 0, where cov stands for covariance. This formulation is an example





A, i = 1, . . . , I.
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We cannot yet separately estimate the two variance components. So now suppose we
have repeated blood pressure measurements, j = 1, . . . , J , for each patient. Then the
jth replicate observation for the ith patient, Yij is given by
Yij = µ+Bi +Aij . (1)
The mean and variance of Yij are as before, but the responses within patient i are
correlated, that is, we can show that cov(Yij , Yij′) = σ
2
B for repeated observations j and
j′. This then leads to the definition of the intraclass correlation coefficient (ICC), which







When ρI is small (that is, close to zero) the repeated measurements within a patient
are only weakly correlated. When ρI is close to one, repeated measurements are highly
correlated and this feature of the data can be exploited to improve the efficiency of
statistical estimators, and to reduce the sample size needed for power calculations at
the design stage of a study. In multilevel model terminology, the patient random vari-
ables Bi are at level two of the model, and the random variables representing repeated
measurements within patients, Aij , are at level one
5.
Cox and Solomon6 analysed quarterly systolic blood pressure measurements observed
on 25 men prescribed oxprenolol in the International Prospective Primary Prevention
Study in Hypertension (IPPPSH). The study was one of several large-scale multi-centre
randomised clinical trials conducted in the 1980s with the aim of establishing a gold stan-
dard target for diastolic blood pressure in the primary prevention of heart disease and
stroke. In this trial, patients were examined at three-monthly visits and both systolic
and diastolic blood pressure measurements were taken in duplicate, five minutes apart.
Figure 1 displays the second recorded (resting) systolic blood pressure measurement for
I = 25 randomly selected adult males at their J = 16 visits over a four-year period.
The individual measurements are observed to range from 105 to 240 mmHg and there is
considerable variability observed both between patients and between repeated measure-
ments within patients. We ignore here possible time trends or serial correlation in the
repeated measurements over time. The overall estimated mean systolic blood pressure is
147.78 mmHg, the estimated component of variance between patients is 182.30 mmHg2,
and the measurement error, that is, the variability between visits within patients, is
185.78 mmHg2. Thus the repeated measures component of variance is high, and the
estimated ratio σ2B/σ
2
A is 0.98. The estimated intraclass correlation coefficient is 0.50,
which is modest. The measurement error component is reduced by transforming the
raw measurements to the log scale; see6, but the data nevertheless demonstrate high
variability in blood pressure measurements both within and between patients.
- Figure 1 here -
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In Section 2, we explain how to obtain the variance component estimates from the
analysis of variance table. Throughout the discussion, we assume the data are balanced
in the sense that each patient has the same number of repeated measurements.
Example 3. Breath analysers: In a recent study, Gullberg7 compared the performance
of six breath analyser machines. 10 replicate blood alcohol measurements were made on
three independent adult male subjects on each machine. The comparative performance of
the six breath analysers is of primary interest in the study, in which the subjects represent
a population of adult males who consume alcohol and the replicate measurements within
subjects/machines represent measurement error. Thus, an appropriate model is one
which treats the breath analyser machines as fixed effects (αi) to be estimated and
the subject effects (Cj) and measurement error (Aijk) as additive random effects with
variance components. We also include a random effect (Bij) for possible interaction
between subjects and machines. This leads to the blood alcohol observation on the ith
analyser, jth subject and kth replicate, Yijk, modelled by
Yijk = µ+ αi + Cj +Bij +Aijk, (3)
where µ is the overall mean, the αi, i = 1, . . . , 6, are the breath analyser fixed effects,






The results of an analysis of simulated data which approximate Gullberg’s results,
with estimates of the fixed effects αi omitted, are shown in Table 1. It should be noted
there were significant differences between some of the breath analyser fixed effects. The
results showed that 95.7% of the variability is explained by differences between subjects,
1.3% by the interaction between breath analyser machines and subjects and 2.9% is
residual variation. It is reassuring that for a given subject, there is relatively little
variation between the breath analysers.
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- Table 1 here -





Example 4. Gastric cancer protein expression data:
In a recent collaboration with Megan Penno and colleagues at the Adelaide Pro-
teomics Centre8 we analysed protein expression levels obtained from a murine gastric
cancer experiment. The experiment was conducted using matrix-assisted laser desorp-
tion/ionisation time-of-flight (MALDI-TOF) mass spectrometry and a primary aim of
the study was to detect biomarkers for gastric cancer in serum. Forty mice belonging
to five different genotype groups were reared until 12 to 14 weeks of age, at which time
blood samples were extracted. The five experimental groups can be grouped into two
groups of primary interest: a gastric cancer group and a control group. The gastric can-
cer genotype group is facilitated using an established murine model where a mutation
in glycoprotein 130 protein coding gene in the mice leads to malignant tumours.
Each blood sample was centrifuged to isolate the serum which was then split into
three aliquots. Each aliquot was further split into three batches and fractionated with
C8 beads which produced nine batches from all aliquots. Finally, each batch was pipet-
ted onto three separate locations on one of the three MALDI-TOF chips used in the
experiment, producing 27 samples per mouse. Notably, all samples that originated from
a particular aliquot were eventually pipetted onto the same chip, leading to confounding
of the chip and aliquot effects. Each chip contained nine samples from the 40 mice, or
360 samples in total. Figure 2 outlines of the process which produced the 27 replicate
samples from one mouse. The raw spectra were pre-processed to adjust for experimental
and other known systematic effects before downstream statistical analysis.
- Figure 2 here -
Chip 3Chip 2Chip 1












A linear mixed model for the pre-processed peak expression data which takes account
of the experimental structure is one with four nested levels of variability, for which a
single observation Yijk` may written as
Yijk` = µ+ βi + α2j + α3j +Di + Cij +Bijk +Aijk`. (4)
7
Components of variance Patty Solomon
The fixed effects and random effects in the model are described in Table 2.
- Table 2 here -
Peak 6821 Da
Type Effect Description Parameter Estimate % Variation
Fixed µ Mean expression µ 9.14
βi Gastric cancer effect βi 0.94
α2j Chip 2 effect α2j -0.56
α3j Chip 3 effect α3j -0.54
Random Di Mouse effect σ
2
D 0.32 55
Cij Aliquot effect σ
2
C 0.07 12
Bijk C8 bead effect σ
2
B 0.09 16
Aijk` Replicate effect σ
2
A 0.10 17
The model was fitted separately to 159 protein peaks with the primary aim of detect-
ing biomarker proteins for gastric cancer. Table 2 gives the results from fitting model (4)
to a single peak with low missingness which is a potential biomarker for gastric cancer,
specifically, a peptide estimated to weigh 6821 Daltons (Da).
It should be noted that the fixed effects are estimated as differences relative to other
fixed effects: α2j and α3j are the effects of chips 2 and 3, respectively, compared to
chip 1. Similarly, βj is the expression effect of gastric cancer mice relative to control
mice and is the effect of primary interest. Table 2 shows that for the 6821 Da peptide,
the effect of gastric cancer relative to control is an increase in expression of 0.94 units.
Chips 2 and 3 are estimated to reduce the expression by 0.56 and 0.54 units, respectively,
relative to chip 1. The estimate for µ is interpreted as the mean expression for a control
mouse on chip 1.
The estimated variance components reveal some interesting insights into the hier-
archal structure of the experimental design. The largest source of variability is the
biological variation between mice (55%). The next largest contribution to the total is
the residual variance (17%) which is likely to be the result of an under-specified model
due to unknown covariates. The smallest contribution to the variance was the third level
component of aliquot (12%), suggesting the partitioned serum samples are largely ho-
mogeneous. The information about the variance components can be utilised to optimise
the experimental design for future studies6.
Figure 3 is a heat-map of an empirical correlation matrix which demonstrates the dif-
ferent levels of correlation between the spectra derived from each mouse; the correlations
are given in descending strength by colour change from dark to light. The heat-map was
constructed by calculating all pairwise correlations of peak expressions for the 27 repli-
cates per mouse, then taking the average correlation matrix over the 40 mice. We observe
that spectra from the same C8 bead fractionation share more similarity than those from
another C8 bead fractionation or spectra derived from a different aliquot/MALDI chip.
The observed correlation matrix was very similar to the theoretical matrix hypothesised
from the model.
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Intraclass correlation coefficients take on a more generalised meaning as ‘class’ can be
interpreted at the different levels of the hierarchical experimental design. For example,














which is estimated to be 0.83 for the single peak related to the 6821 Da peptide, consistent
with Figure 3.
Example 5. Comparison of oropharyngeal pH monitoring devices: In 2013, Yuksel et
al9 performed in vitro studies to systematically study the performance characteristics
of a new oropharyngeal pH monitoring probe with a standard device in patients with
chronic laryngitis. 136, 127 observations were made of eosophageal pH using the (new)
oropharyngeal device and the conventional device. A random sample of 100 pairs of
observations are plotted in Figure 4, which shows a strong positive linear relationship
with an estimated correlation coefficient of 0.96. The blue line in Figure 4 is the ‘zero
line’, which represents complete agreement between the two devices. It is apparent that
the conventional device produces consistently higher pH readings than the new device.
The observed bias can be quantified using the Bland-Atman plot10, which plots the
average pH values versus the differences in pH. We revisit this example in Section 3 on
interobserver agreement.
- Figure 4 here -
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2 Analysis of variance
The analysis of variance (ANOVA) was introduced by R.A. Fisher as a statistical hy-
pothesis testing approach for comparing two or more population means1, generalising the
two-sample t-test for comparing two population means. ANOVA is based on partitioning
the observed variability in the data into parts using sums of squares (SS) of the data.
A key assumption is that if there are no differences between a set of I population (or
group) means, then the corresponding sum of squares between groups behaves like the
random error sum of squares. In particular, the ratio of the between groups SS divided
by its degrees of freedom to the error SS divided by its degrees of freedom should then
be close to one.
The sums of squares result from a linear decomposition of the ith observation in the
jth group, Yij , for which we can write
Yij = Y.. + (Yi. − Y..) + (Yij − Yi.), (5)
where the dots are equal to averages over the observed array. For illustration, consider
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The degrees of freedom associated with the three vectors may be explained geometrically
as follows. For 2×3 = 6 observations, the number of dimensions in which the observations
can vary is equal to 6; here I = 2 and J = 3 hence IJ = 6. There is one degree of
freedom for the mean Y.., because if any one value in the mean vector is known, they are
all known. There are I = 2 values in the vector of deviations about the overall sample
mean, but by knowing one value, the second can be determined. For each I, knowing
3 − 1 = 2 values determines the last value, leading to 2(3 − 1) = 4 degrees of freedom
for the within-group component. In general, there are I(J − 1) degrees of freedom.
Returning to equation (5) and subtracting Y.. from both sides yields,
(Yij − Y..) = (Yi. − Y..) + (Yij − Yi.). (6)
From equation (6) it can be seen that the difference between an observation and the
overall mean (Yij − Y..) can be separated into two components. Namely, the difference
between the group mean from the overall mean (Yi.−Y..) and the difference between the
observation from the group mean (Yij − Yi.). Squaring both sides of equation (6) and
summing over all groups and observations within groups for the example with I = 2 and






which in turn equals the sum of two terms on the right hand side of equation (6) squared:
the first is the between-group sum of squares (SSB) and the second is the within-group











Note that the cross-terms vanish when squaring and summing over i and j on the right
hand side of equation (6). The resulting sum of squares identity is simply an application
of Pythagoras’s Theorem and this is illustrated in Figure 5.
– Figure 5 goes here –
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c2 = a2 + b 2
(Y i . − Y ..)
(Y i j − Y i .)



















(Y i j − Y i .)2
Figure 6 shows how each of the squared differences (Yij − Y..)2, (Yij − Yi.)2, and
(Yi. − Y..)2, can be visualised on a hypothetical set of data with I = 4 and J = 5. The
data were randomly generated observations from a normal distribution with a standard
deviation of two rounded to the nearest integer. Each of the I = 4 groups shared a
common mean of six so it is expected that the SSB should be small relative to the
SST. This is an illustrative scenario similar to the decomposition shown in Figure 1 of
Example 2.





















































In general, for I groups and J repeated measurements within groups, the decom-
position of the total sum of squares is given in the analysis of variance table, Table 3.
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The mean square (MS) in each case is the sum of squares divided by the appropriate
number of degrees of freedom. For example, the mean squares between groups is MSB
= SSB/(I − 1).
– TABLE 3 goes here –
Estimating the variance components: For the one-way blood pressure model in equation
(1), we can show that the expected mean squares between groups is E(MSB) = Jσ2B+σ
2
A





and σ2A by MSE. These are known as the least squares-based estimates of the variance
components and are unbiased. These are the formulae we used to calculate the variance
component estimates for systolic blood pressure given in Example 2. If we additionally
assume that all the random variables are normally distributed, formal statistical infer-
ence and importantly, significance tests are possible. Specifically, under the normality
assumption, the sums of squares are independently distributed proportionally to chi-
squared random variables with the appropriate degrees of freedom. Hence, normality
gives rise to the familiar F -statistic, MSB/MSE, for testing the null hypothesis of no
differences between the group means.
So far, we have assumed that the data are balanced, in the sense that there is an equal
number of repeated measurements in each group. ANOVA works best when the data are
balanced. When the data are unbalanced, the statistical principles are the same but the
estimation is more complicated. There are numerous computational software solutions
available for both ANOVA and the estimation of variance components from balanced
and unbalanced data, and we discuss these in Section 5 on software and computational
issues.
3 Interobserver agreement
Often the analysis of interest centres on the agreement between two (or more) observers.
If the outcome is continuous and each observer measures the outcome, Pearson’s corre-
lation coefficient, r, provides an empirical measure of agreement. Further, this is related
to the coefficient of determination, r2, which provides an estimate of the proportional
variance shared by two observers. The closer the coefficient of determination is to one,
the closer the agreement between the two observers.
To see how correlation and variance are related, consider the following equation






This is the formula which leads to the intraclass correlation coefficient ρI given in
equation (2) for the one-way model. For intraclass correlation, the random variables X
13
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and Y represent repeated measurements on the same individual, that is, (X = Yij , Y =
Yij′), so that cov(X,Y ) = σ
2





Bland and Altman10 point out that correlation is not sufficient for measuring inter-
observer agreement because, amongst other issues, the correlation coefficient does not
provide information about bias. That is, whether one observer consistently reports larger
or smaller values than the other observer. Figure 7 shows the data on eosophageal pH
from Example 5 again in a scatter plot (left tableau) and a Bland-Altman plot on the
right. The Bland-Altman plot gives the average observer values on the x-axis and the
difference between the observer values on the y-axis. The plot essentially removes the
y = x trend seen in the scatter plot (left) to enable explicit examination of the observer
values. The bias can be seen clearly in the right plot with the solid orange line depicting
the mean difference in the observer (device) pH measurements. Once again variance is
an important element of the agreement analysis. The dotted orange lines give an ap-
proximate 95% prediction interval for the differences between the two observers, known
as the limits of agreement. These are statistical bounds. In practice, such predicted
limits of maximum differences should be specified prior to the analysis, and based on
clinical knowledge and the variability that would be tolerated between observers.
- Figure 7 here -



































































































































































































































Example 5 represents a simple situation in which there are two observers and a
continuous outcome variable. Often there are more than two observers, such as in
the comparison of breath analysers in Example 3, or the outcomes are not continuous
variables, such as diagnostic categories, or the outcomes are not paired. In cases where
the interobserver agreement is measured for categorical outcomes, Cohen’s Kappa is
commonly used.
4 Practice points
Before conducting an experiment or collecting data, the following questions should be
answered, ideally in collaboration with a statistician:
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• Establish the scientific question to be answered from your data.
• What is the outcome variable of interest? Is it continuous, discrete or ordinal?
• What variables are associated with this outcome? Are they continuous, discrete
or ordinal?
• What are the likely systematic influences on the outcome? These determine the
fixed effects in the model.
• What are the potential sources of variability? These determine the components of
variance in the model.
• Are there repeated measures in the data?
– If so, are temporal or spatial effects likely in the data?
• Will randomization or random sampling be appropriately employed in the experi-
ment or study?
– If your data are observational, then batch effects arising from the study design
or sampling process can affect the statistical efficiency of clinical effects of
interest.
5 Statistical software and computational issues
In most cases, using statistical software to calculate estimates of variance components
is recommend since hand calculations can be tedious and prone to errors. Fortunately,
there are numerous software packages available that can calculate variance components
when provided with data. The following recommendations are not exhaustive and focus
on procedures to calculate ANOVA tables and fit linear mixed effects models.
The free software package R provides a function called aov() to calculate ANOVA
tables. When there are two or or more random effects in a model, lme() in the nlme
package is recommended. The function lmer() in the lme4 package can also fit linear
mixed models. SAS is another popular software package and also has a range of proce-
dures available to estimate variance components. The aptly named PROC ANOVA allows
users to produce ANOVA tables from data, while PROC VARCOMP and PROC MIXED will
fit linear models with random effects.
Once data are loaded into the statistical software SPSS, analysis routines can be se-
lected under ‘Analyze’ on the toolbar. A simple ANOVA can be selected under Compare
Means > One-Way ANOVA. General Linear Model > Univariate and General Linear
Model > Variance Components allow fixed and random effects to be specified in the lin-
ear model. These routines can also be run using ‘Syntax’ commands in lieu of the
menu driven options mentioned above. The software package Stata is also widely
used in the health sciences. ANOVA tables can be produced using the anova com-
mand or by selecting Statistics > Linear models and related > ANOVA/MANOVA >
15
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Analysis of variance and covariance. Linear models with mixed effects can be fit-
ted using the mixed command or by selecting Statistics > Multilevel mixed-effects
models > Linear regression.
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Tables
Table 1. Estimated components of variance and percentage of total variance for the
breath analyser study; see main text Example 3.





Table 2. Fixed effects and variance component estimates for the linear model (4) fitted
to the proteomic expression data; see main text Example 4. The parameter estimates
are for the model fitted to the peptide measured at 6821 Da.
Peak 6821 Da
Type Effect Description Parameter Estimate % Variation
Fixed µ Mean expression µ 9.14
βi Gastric cancer effect βi 0.94
α2j Chip 2 effect α2j -0.56
α3j Chip 3 effect α3j -0.54
Random Di Mouse effect σ
2
D 0.32 55
Cij Aliquot effect σ
2
C 0.07 12
Bijk C8 bead effect σ
2
B 0.09 16
Aijk` Replicate effect σ
2
A 0.10 17
Table 3. Analysis of variance (ANOVA) table for the one-way model, equation (1)
Source of variation Sum of squares df∗ Mean squares
Between groups (SSB)
∑I










j=1(Yij − Y..)2 IJ − 1
∗Degrees of freedom
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List of figures
Figure 1. Quarterly systolic blood pressure measurements over four years for 25 adult
males from the International Prospective Primary Prevention Study in Hypertension;
see main text Example 2. The sums of squares SST, SSB and SSE are defined in Table
3.
Figure 2. Experimental design for the gastric cancer MALDI-TOF mass spectrometry
study; see main text Example 4.
Figure 3. Heat-map of the empirical pairwise correlation structure for the peak expres-
sions between the 27 spectra obtained from each mouse in the gastric cancer experiment.
The correlations are shown in descending strength in colour change from dark to light;
see main text Example 4.
Figure 4. Eosophageal pH for a conventional versus a new monitoring device for a
random sample of 100 observations; see main text Example 5.
Figure 5. Pythagoras’s Theorem (left tableau). Geometric representation of the decom-
position of an observation vector into its uncorrelated parts, resulting in the sums of
squares identity for the analysis of variance (right tableau). The decomposition in the
balanced case is Pythagoras’s Theorem.
Figure 6. Visualisation of the sums of squares leading to the analysis of variance table
for a hypothetical one-way model with I = 4 groups and J = 5 replicate measurements
within each group.
Figure 7. Bland-Altman plot for agreement between a conventional device and a new
device for monitoring eosophageal pH; see main text Example 5.
18
